Our world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
We are one of the world’s leading over-the-counter (OTC) healthcare companies with number one positions in a number of markets, including the US, India and Germany. Our portfolio of loved and trusted brands includes Sensodyne, Paradontax, Polident, Advil, Voltaren, Panadol, Otrivin, Theraflu and Centrum.
Bankers for Net Zero brings together banks, businesses and regulators to enable banks to successfully support their clients, accelerate the transition to net zero and deliver on the UK government’s ambitions for addressing climate change.
Backed by The All Party Parliamentary Group (APPG) on Fair Business Banking, Volans and Re:Pattern, the initiative encompasses an ambitious programme of work to develop a policy recommendations ahead of COP26, designed to create a regulatory environment that enables banks to play their part in financing the net-zero transition. Bankers for NetZero is part of the UK’s Finance Coalition for COP26, which is led by the Carbon Disclosure Project (CDP) and the World Wildlife Fund (WWF). It includes the UK Sustainable Investment and Finance Association (UKSIF), the Institutional Investors Group on Climate Change (IIGCC), United Nations Principle for Responsible Investment (UN PRI), Make My Money Matter and Bankers for NetZero.
The coalition is focused on mobilising financial institutions for climate action and collectively encouraging their stakeholders to set high ambition commitments from the financial sector at COP26. Bankers for Net Zero has applied to join the Climate Champion Team’s Race to Zero as a partner, and are currently working with the COP26 team ahead of the summit to encourage as many banks to sign up to the Race to Zero as possible.